Polomar Health Services, Inc. (PMHS) intrinsic value & 10-year financials
Polomar Health Services, Inc. (PMHS) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 5 fiscal years revenue grew 165.8% a year to $648.2K, with an average return on invested capital of -322.2%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $0.12
- Market cap
- $3.5M
- Revenue (FY2025)
- $648.2K
- Revenue growth (5-yr CAGR)
- 165.8%
- ROIC (10-yr avg)
- -322.2%
- Free cash flow (FY2025)
- —
PMHS 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $648.2K | -$10.7M | -$0.39 | — | -1627.5% | — |
| FY2024 | $58.8K | -$1.3M | -$0.05 | -$1.1M | -2209.1% | -30.9% |
| FY2023 | $41.8K | -$416.5K | -$0.02 | — | -644.8% | -613.4% |
| FY2022 | $34.5K | -$181.1K | $0.00 | — | -525.6% | — |
| FY2021 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Polomar Health Services, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Polomar Health Services, Inc. has historically struggled to out-earn its cost of capital, averaging just -18.5% ROIC.
Polomar Health Services, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Polomar Health Services, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-12.95 per share.